Axumin

Active Ingredient(s): Fluciclovine
FDA Approved: * May 27, 2016
Pharm Company: * BLUE EARTH DIAGNOSTICS LTD
Category: Diagnostic Aid

Fluciclovine (18F), also known as anti-1-amino-3-18F-fluorocyclobutane-1-carboxylic acid (anti-3[18F] FACBC),[1][2] or as Axumin (brand name), is a diagnostic agent indicated for positron emission tomography (PET) imaging in men with suspected prostate cancer recurrence based on elevated prostate specific antigen (PSA) levels.[3][4] Contents 1 Background 2 Mechanism 3 Marketing 4 References 5 External links Background Most... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Axumin 221 mci/Ml Intravenous Injection, Solution
NDC: 69932-001
Labeler:
Blue Earth Diagnostics